Results 171 to 180 of about 5,214,305 (354)

Biological Complementary Therapies: A Focus on Botanical Products in Diabetes [PDF]

, 2001
Laura Shane‐McWhorter
openalex   +1 more source

Transcriptome‐wide analysis of circRNA and RBP profiles and their molecular relevance for GBM

Molecular Oncology, EarlyView.
CircRNAs are differentially expressed in glioblastoma primary tumors and might serve as therapeutic targets and diagnostic markers. The investigation of circRNA and RNA‐binding proteins (RBPs) interactions shows that distinct RBPs play a role in circRNA biogenesis and function.
Julia Latowska‐Łysiak, Żaneta Zarębska, Marcin P. Sajek, Adriana Grabowska, Alessia Buratin, Paweł Głodowicz, Julia O. Misiorek, Konrad Kuczyński, Stefania Bortoluzzi, Marek Żywicki, Jan G. Kosiński, Agnieszka Rybak‐Wolf, Rafał Piestrzeniewicz, Anna M. Barciszewska, Katarzyna Rolle   +14 more
wiley   +1 more source

Use of complementary therapies by registered psychologists:An international study [PDF]

, 2015
Boucher, Emma, Chatwin, Hannah, Crebbin, Sue, Purkis, Gail, Scott, Sandra, Smith, Dean, Stapleton, Peta   +6 more
core   +1 more source

First national survey of anthroposophic nurses in NZ [PDF]

, 2018
Anthroposophic health care although listed as a Complementary and Alternative Medicine (CAM) – approach according to the Ministerial Advisory Committee for Complementary and Alternative Health (MACCAH, 2002;2004) in New Zealand (NZ), is an integrated ...
Te Huia, Maria
core  

A Step-by-Step Approach to Complementary Therapies [PDF]

, 2001

openalex   +1 more source

Targeting the MDM2‐MDM4 interaction interface reveals an otherwise therapeutically active wild‐type p53 in colorectal cancer

Molecular Oncology, EarlyView.
This study investigates an alternative approach to reactivating the oncosuppressor p53 in cancer. A short peptide targeting the association of the two p53 inhibitors, MDM2 and MDM4, induces an otherwise therapeutically active p53 with unique features that promote cell death and potentially reduce toxicity towards proliferating nontumor cells.
Sonia Valentini, Giada Mele, Marika Attili, Maria Rita Assenza, Fulvio Saccoccia, Francesca Sardina, Cinzia Rinaldo, Roberto Massari, Nicola Tirelli, Alfredo Pontecorvi, Fabiola Moretti   +10 more
wiley   +1 more source

Advancing Precision Oncology Through Modeling of Longitudinal and Multimodal Data [PDF]

arXiv
Cancer evolves continuously over time through a complex interplay of genetic, epigenetic, microenvironmental, and phenotypic changes. This dynamic behavior drives uncontrolled cell growth, metastasis, immune evasion, and therapy resistance, posing challenges for effective monitoring and treatment.
arxiv  

The experience of a program combining two complementary therapies for women with breast cancer: An IPSE qualitative study. [PDF]

PLoS One, 2023
Sibeoni J, Manolios E, Mathé J, Feka V, Vinez MM, Lonsdorfer-Wolf E, Bloch JG, Baylé F, Meunier JP, Revah-Levy A, Verneuil L.   +10 more
europepmc   +1 more source

Secondary Data Analysis: A Non-Pharmacology Treatment for Individuals Living with HIV/AIDS

, 2017
At the end of 2015, 36.7 million people were living with HIV/AIDS world wide (WHO, 2017). Living with this disease puts individuals at increased risk for mental and physical health complications.
Dodge-Francis, Carolee, Ed.D, Jean, Joseph   +1 more
core  

Evolution and Complementarity? Traditional and Complementary Medicine as Part of the International Human Rights Law Right to Health [PDF]

, 2020
In International Human Rights Law, the International Covenant on Economic, Social and Cultural Rights defines the right to health as the right of everyone to the enjoyment of the highest attainable standard of physical and mental health.
Carne, Greg, Doolan, Angela
core